5 Must-Buy Efficient Stocks to Buy Amid Volatile Market Conditions
Tsakos Energy Navigation, 10x Genomics, Pan American Silver, Wolverine World Wide, and Interface top an efficiency-driven stock screen.
10x Genomics ( TXG ) Surpasses Q2 Earnings and Revenue Estimates
10x Genomics (TXG) delivered earnings and revenue surprises of +180.00% and +24.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
10x Genomics ( TXG ) Upgraded to Buy: Here's Why
10x Genomics (TXG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Tempus AI Stock Before Q2 Earnings Release: To Buy or Not to Buy?
TEM surged 34.5% in Q2 on AI-driven deals and product momentum, but valuation and profit concerns linger ahead of earnings.
3 Medical Info Systems Stocks to Buy Amid AI Boom and Tariff Risk
AI momentum and rising demand for digital care put Zacks Medical Info Systems industry stocks like VEEV, TXG and IMDX in focus despite new tariff headwinds.
Genomics Market to Hit US$66.8 Billion by 2029 with 9.4% CAGR | MarketsandMarkets™.
Delray Beach, FL, June 11, 2025 ( GLOBE NEWSWIRE ) -- The global genomics market, valued at US$42.4 billion in 2023, stood at US$42.6 billion in 2024 and is projected to advance at a resilient CAGR of 9.4% from 2024 to 2029, culminating in a forecasted valuation of US$66.8 billion by the end of ...
What's Driving the Market Sentiment Around 10x Genomics? - 10x Genomics ( NASDAQ:TXG )
10x Genomics's TXG short percent of float has fallen 6.23% since its last report. The company recently reported that it has 14.88 million shares sold short, which is 20.03% of all regular shares that are available for trading.
Cathie Wood Sells Tesla Stock As Chinese Rivals Gain Ground - Ark Dumps Palantir Amid Privacy Concerns - ARK Innovation ETF ( BATS:ARKK ) , Palantir Technologies ( NASDAQ:PLTR )
On Monday, Cathie Wood-led Ark Invest made significant trades, notably offloading shares of Tesla Inc. TSLA and Palantir Technologies Inc. PLTR. The Tesla Trade: Ark Invest sold 1,594 shares of the Elon Musk-led company.
Wall Street Analysts Think 10x Genomics ( TXG ) Could Surge 43.12%: Read This Before Placing a Bet
The average of price targets set by Wall Street analysts indicates a potential upside of 43.1% in 10x Genomics (TXG). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Cathie Wood Reiterates 'Profound' AI Application In Healthcare As Researchers Discover 'Cancer Survival Outcomes' By Facial Photograph Analysis: Here Are The Stocks That Could Benefit - Invesco QQQ Trust, Series 1 ( NASDAQ:QQQ ) , Illumina ( NASDAQ:ILMN )
Cathie Wood, the founder, CEO, and CIO of Ark Invest, underscored the application of artificial intelligence in the healthcare sector by sharing new research by Mass General Brigham, citing the discovery of cancer survival using facial photograph analysis.
Why 10x Genomics Stock Was Sliding This Week
Gene sequencing technology company 10x Genomics ( NASDAQ: TXG ) hasn't been having it easy in the past few days on the stock market. A bearish analyst move dampened sentiment on the company, and according to data compiled by S&P Global Market Intelligence its price was down by more than 9% week ...
10x Genomics ( TXG ) Upgraded to Buy: Here's What You Should Know
10x Genomics (TXG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Wall Street Analysts Believe 10x Genomics ( TXG ) Could Rally 55.85%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 55.9% in 10x Genomics (TXG). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Cathie Wood Says AI Innovation In Healthcare Will Be More 'Profound' Than Autonomous Taxi Networks, Humanoid Robots - Amgen ( NASDAQ:AMGN ) , Bristol-Myers Squibb ( NYSE:BMY )
The Founder, CEO, and CIO of Ark Invest, Cathie Wood, has highlighted the rising applications of artificial intelligence and how it is poised to impact not only autonomous taxi networks and humanoid robots but also the health care space.
10x Genomics CEO Calls NIH The 'Foundational Jewel' Of Biomedical Progress, Says 40% To 50% Of Revenue Supported By Academic And Government Research Funding - Pulls Full Year Revenue Guidance - 10x Genomics ( NASDAQ:TXG )
During its first-quarter earnings call on Thursday, 10x Genomics Inc. TXG withdrew its full-year guidance, opting instead to provide quarterly forecasts. What Happened: The company cited policy uncertainty stemming from recent U.S. government budget cuts for academic research as the reason for ...
10x Genomics ( TXG ) Reports Q1 Loss, Tops Revenue Estimates
10x Genomics (TXG) delivered earnings and revenue surprises of 20% and 16.24%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Cathie Wood Pours $9.8 Million In Robinhood Despite Crypto Revenue Slump, Keeps Dumping Palantir Ahead Of Earnings - Advanced Micro Devices ( NASDAQ:AMD ) , ARK Innovation ETF ( BATS:ARKK )
On Thursday, Cathie Wood-led Ark Invest made significant trades involving Robinhood Markets Inc. HOOD, Advanced Micro Devices Inc. AMD, and Palantir Technologies Inc. PLTR. The Robinhood Trade saw Ark Invest's ARK Innovation ETF ARKK fund acquire 210,714 shares of Robinhood Markets Inc.
10x Genomics ( TXG ) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
10x Genomics (TXG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cathie Wood Sells Palantir Shares Worth $2.65 Million Ahead Of Earnings, Doubles Down On This Chip Giant - Advanced Micro Devices ( NASDAQ:AMD ) , ARK Innovation ETF ( BATS:ARKK )
On Wednesday, Cathie Wood-led Ark Invest executed significant trades involving Palantir Technologies Inc. PLTR, Advanced Micro Devices Inc. AMD, and Shopify Inc. SHOP. Ark Invest made a notable move by selling shares of Palantir Technologies Inc.
Tempus AI Stock Surges 43% in Q1: Buy Now or Wait for Earnings?
TEM's Genomics unit is expected to report strong growth for the first quarter, banking on continued unit growth pick-up.
Cathie Wood Buys More NVIDIA And AMD Stock As Chinese Tech Giants Stockpile Chips Amid Looming US Export Curbs - Advanced Micro Devices ( NASDAQ:AMD ) , Adaptive Biotechnologies ( NASDAQ:ADPT )
On Wednesday, Cathie Wood-led Ark Invest increased its exposure to NVIDIA Corp NVDA and Advanced Micro Devices Inc AMD. These trades come amid ongoing challenges in the semiconductor industry, particularly with U.S. sanctions affecting chip sales to China.
Cathie Wood's Thursday Plays: Healthcare AI And Crypto - Ark Scoops Up Tempus AI and Coinbase Stock Amid Trump Tariff Crash - Coinbase Global ( NASDAQ:COIN ) , ARK Innovation ETF ( BATS:ARKK )
On Thursday, Cathie Wood-led Ark Invest made notable trades, prominently featuring Tempus AI Inc TEM and Coinbase Global Inc COIN. The trades came as Wall Street reversed Wednesday's rally with a sharp selloff, as cooling inflation and hopes for Fed cuts were overshadowed by economic uncertainty ...
Life Science Company 10x Genomics Struggles With Profitability, Analyst Says 2025 Guidance Bakes In NIH Funding Uncertainties - 10x Genomics ( NASDAQ:TXG )
10x Genomics posted a Q4 EPS loss of $ ( 0.40 ) , missing the $ ( 0.30 ) estimate. The company's 2025 sales guidance of $610M-$630M is below the $631.14M consensus. Get access to your new suite of high-powered trading tools, including real-time stock ratings, insider trades, and ...
MGM Resorts To Rally Around 75%? Here Are 10 Top Analyst Forecasts For Thursday - Mr. Cooper Gr ( NASDAQ:COOP ) , Dutch Bros ( NYSE:BROS )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Needham raised Reddit, Inc. RDDT price target from $190 to $220. Needham analyst Laura Martin maintained a ...
10x Genomics ( TXG ) Reports Q4 Loss, Tops Revenue Estimates
10x Genomics (TXG) delivered earnings and revenue surprises of -25% and 0.03%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Seeking Clues to 10x Genomics ( TXG ) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for 10x Genomics (TXG), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2024.
Cathie Wood's Ark Invest Bets Big On Amazon, Roblox And Illumina While Trimming Palantir Stake After Alex Karp-Led Company Touched An All-Time High On Thursday
On Friday, Cathie Wood's Ark Invest made significant trades involving a number of prominent companies such as Amazon.com Inc AMZN, Robinhood Markets Inc HOOD, Palantir Technologies Inc PLTR, and Roblox Corp RBLX, among others.
Cathie Wood Sells Palantir Shares As Rally Cools Down, Ark Invest Also Dumps Nearly $7 Million Worth Of Robinhood Stock - ARK Innovation ETF ( ARCA:ARKK )
On Wednesday, Cathie Wood-led Ark Invest made significant trades involving Palantir Technologies Inc. PLTR and Robinhood Markets Inc. HOOD. These trades occurred amid notable developments in both companies, drawing attention from investors and market analysts.
10x Genomics ( TXG ) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
10x Genomics (TXG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cathie Wood-Led Ark Invest Dumps $7M Worth Of Palantir Stock Amid Searing Rally - ARK Innovation ETF ( ARCA:ARKK ) , Palantir Technologies ( NASDAQ:PLTR )
On Tuesday, Cathie Wood-led Ark Invest made notable trades, including the sale of shares in Palantir Technologies Inc PLTR. This move came as Palantir's stock surged following its impressive fourth-quarter results and optimistic future guidance.
Cathie Wood's Ark Invest Bets On Biotech With CRISPR Therapeutics Investment, Exits Roblox - Archer Aviation ( NYSE:ACHR ) , Accolade ( NASDAQ:ACCD )
On Friday, Cathie Wood-led Ark Invest made significant trades involving CRISPR Therapeutics AG CRSP, 10X Genomics Inc. TXG, Roblox Corp. RBLX, Archer Aviation Inc. ACHR, Nu Holdings Ltd. NU, Adyen NV ADYEY, Accolade Inc. ACCD, and AeroVironment Inc. AVAV.
Cathie Wood's Ark Invest Dumps Over $10 Million Worth Of Palantir Stock As AI Competition Heats Up - Archer Aviation ( NYSE:ACHR ) , ARK Innovation ETF ( ARCA:ARKK )
On Thursday, Cathie Wood-led Ark Invest made significant trades involving Palantir Technologies Inc. PLTR. Ark Invest's decision to sell Palantir Technologies Inc. PLTR shares on Thursday comes amid a backdrop of competitive pressures in the AI space.
Tempus AI Stock Before Q4 Earnings: To Buy or Not to Buy?
TEM's Genomics unit is expected to report strong growth for the fourth quarter, banking on continued unit growth pick-up.
Here's Why You Should Retain PacBio Stock in Your Portfolio for Now
PACB continues to deliver growth from its unique technologies amid business seasonality concerns.
RNA Transcriptome Profiling Tests Market Expands at 14.5% CAGR, Surpassing US$ 37 Billion by 2034 | Fact.MR Report
Rockville, MD, Jan. 20, 2025 ( GLOBE NEWSWIRE ) -- According to Fact.MR, a market research and competitive intelligence provider, the global RNA transcriptome profiling test market is estimated to reach a valuation of US$ 9,652.2 million in 2024 and is expected to grow at a CAGR of 14.5% during ...
Cathie Wood's Pre-Christmas Sale: Ark Invest Dumps Even More Tesla, Palantir Stock - ARK Innovation ETF ( ARCA:ARKK )
A day before Christmas, on Tuesday, Cathie Wood-led Ark Invest made significant adjustments to its portfolio, notably selling shares of Tesla Inc. TSLA, Palantir Technologies Inc. PLTR, and Block Inc. SQ. Notably, Ark has been shedding shares of both Palantir and Tesla this week.
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
The aggressive growth fund investor has slowed her shopper this holiday season, but she still made time to build up some of her existing positions.
Cathie Wood-Led Ark Invest's Monday Moves: Dumps Tesla, Palantir Stock, Adds Amazon - ARK Fintech Innovation ETF ( ARCA:ARKF ) , Amazon.com ( NASDAQ:AMZN )
On Monday, Cathie Wood-led Ark Invest executed notable trades involving Tesla Inc. TSLA, Amazon.com Inc. AMZN, and Palantir Technologies Inc. PLTR.
Reasons to Retain PacBio Stock in Your Portfolio for Now
PACB continues to deliver growth from its unique technologies amid business seasonality concerns.
Cathie Wood's Tech Rotation: Amazon Mega-Buy While Tesla, Reddit And Palantir Get Axed - ARK Fintech Innovation ETF ( ARCA:ARKF ) , Amazon.com ( NASDAQ:AMZN )
On Thursday, Cathie Wood-led Ark Invest made significant trades, with Palantir Technologies Inc. PLTR, Tesla Inc. TSLA, Reddit Inc. RDDT, and Amazon.com, Inc AMZN taking center stage. Ark Invest's move to sell Palantir shares comes amid a tumultuous day for the company.
These Analysts Boost Their Forecasts On 10x Genomics After Q3 Results - 10x Genomics ( NASDAQ:TXG )
10x Genomics, Inc. TXG reported a loss for the third quarter on Tuesday. The company posted a quarterly loss of 30 cents per share, compared to market expectations for a loss of 34 cents per share. The company reported quarterly sales of $151.654 million which missed the analyst consensus ...
10x Genomics ( TXG ) Reports Q3 Loss, Tops Revenue Estimates
10x Genomics (TXG) delivered earnings and revenue surprises of 11.76% and 0.02%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Medical Systems, 10x Genomics and Omnicell
Medical Systems, 10x Genomics and Omnicell have been highlighted in this Industry Outlook article.
Lower Volume Likely to Hurt GE HealthCare's Q3 Earnings
GEHC's third-quarter results are likely to witness declining segmental revenues in imaging, ultrasound and patient care. The bottom-line figure may reflect better pricing.
Lower Instruments Sales to Hurt TXG Q3 Earnings, Prelim Sales Down
Per a preliminary report from 10x Genomics, the company's revenues will decline for the third quarter. Lower Instruments sales are likely to have been partially offset by consumable sales growth.
3 Medical Info Systems Stocks to Gain From Healthcare Digitization
Zacks Medical Info Systems industry stocks like Inspire Medical Systems, 10x Genomics and Omnicell are expected to gain from the GenAI wave.
10x Genomics ( TXG ) Upgraded to Strong Buy: Here's Why
10x Genomics (TXG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
American Well Corporation ( AMWL ) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
American Well (AMWL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
10x Genomics ( TXG ) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
10x Genomics (TXG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PacBio Onso™ Short Read Sequencing Instrument Joins 10x Genomics Compatible Partner Program
MENLO PARK, Calif., Oct. 22, 2024 ( GLOBE NEWSWIRE ) -- PacBio ( Nasdaq: PACB ) , a leading developer of high-quality, highly accurate genomic sequencing solutions, today announced the inclusion of the Onso short-read sequencing platform in the 10x Genomics Compatible Partner Program.
